Latest news

MorphoSys (NASDAQ:MOR) is set to give its latest quarterly earnings report on Wednesday, 2022-03-16. Here's what investors need to know before the announcement. Analysts estimate that MorphoSys will report an earnings per share (EPS) of $-0.73.

MorphoSys AG (NASDAQ:MOR) has reported a non-cash impairment charge of €231 million on goodwill after consolidating research and discovery functions. This…

    On Monday, 524 stocks hit new 52-week lows.

    On Friday, 368 stocks hit new 52-week lows.

    During Tuesday's trading, 505 companies set new 52-week lows.

    On Friday, 313 companies hit new 52-week lows.

    On Thursday, 147 companies achieved new lows for the year.

Morgan Stanley analyst James Quigley downgrades MorphoSys (NASDAQ:MOR) from Overweight to Equal-Weight.

    On Thursday, 615 stocks hit new 52-week lows.

Gainers BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered into a Master Service Agreement with PRC Clinical, a contract research organization (CRO), to conduct BioRestorative's Phase 2 trial.